Advertisement
FOR YOUNEWSLIFESTYLETECHENTERTAINMENTSPORTSBUSINESSFOR YOUNEWSLIFESTYLETECHENTERTAINMENTSPORTSBUSINESSFOR YOUNEWSLIFESTYLETECHENTERTAINMENTSPORTSBUSINESS
Gallery 1 / 1
Link copied to clipboard

The menopause of the future is on its way… but is it what we really want?

  • Columbia University is testing rapamycin to slow ovarian aging, showing promising results in trials with human applications.
  • The UK has approved elinzanetant, a non-hormonal drug for hot flushes, offering options for women unable to take HRT, though costly and limited in availability.
  • Future menopause care may focus on multidisciplinary approaches, emphasizing lifestyle and personalized genomics to manage symptoms. Read more

Redirecting to home page in 3s